Hepatocellular carcinoma (HCC): Current and evolving therapies

R. G. Gish; A. Baron

Hepatocellular carcinoma (HCC): Current and evolving therapies

R. G. Gish
, A. Baron

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	198-203
Number of pages	6
Journal	IDrugs
Volume	11
Issue number	3
State	Published - Mar 2008
Externally published	Yes

ASJC Scopus Subject Areas

Pharmacology
Drug Discovery

Keywords

Chemoembolization
Hepatocellular carcinoma (HCC)
Kinase inhibitors
Percutaneous ablation
Sorafenib

OpenUrl availability

Full text

Cite this

@article{113e27d367b54437979f121b3fe73d33,

title = "Hepatocellular carcinoma (HCC): Current and evolving therapies",

keywords = "Chemoembolization, Hepatocellular carcinoma (HCC), Kinase inhibitors, Percutaneous ablation, Sorafenib",

author = "Gish, \{R. G.\} and A. Baron",

year = "2008",

month = mar,

language = "English",

volume = "11",

pages = "198--203",

journal = "IDrugs",

issn = "1369-7056",

number = "3",

}

TY - JOUR

T1 - Hepatocellular carcinoma (HCC)

T2 - Current and evolving therapies

AU - Gish, R. G.

AU - Baron, A.

PY - 2008/3

Y1 - 2008/3

KW - Chemoembolization

KW - Hepatocellular carcinoma (HCC)

KW - Kinase inhibitors

KW - Percutaneous ablation

KW - Sorafenib

UR - https://www.scopus.com/pages/publications/40049097814

UR - https://www.scopus.com/pages/publications/40049097814#tab=citedBy

M3 - Review article

C2 - 18311657

AN - SCOPUS:40049097814

SN - 1369-7056

VL - 11

SP - 198

EP - 203

JO - IDrugs

JF - IDrugs

IS - 3

ER -

Hepatocellular carcinoma (HCC): Current and evolving therapies

ASJC Scopus Subject Areas

Keywords

OpenUrl availability

Other files and links

Cite this